Predicting postoperative renal insufficiency in patients undergoing nephrectomy for renal malignancy: Assessment by renal scintigraphy using 99mtechnetium-mercaptoacetyltriglycine

Journal of Urology

Volumn 173, Issue 2, 2005, Pages 388-390

  Shirasaki, Yoshinori ^a   Saika, Takashi ^a   Tsushima, Tomoyasu ^a   Nasu, Yasutomo ^a   Arata, Ryoji ^a   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Creatinine; Kidney; Kidney neoplasms; Nephrectomy; Radionuclide imaging

Indexed keywords

CREATININE; MERTIATIDE TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALE; MALIGNANT NEOPLASTIC DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; UNINEPHRECTOMY; UROGENITAL TRACT CANCER;

EID: 12544253137     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000149980.61593.5f     Document Type: Article

References (12)

1. Blaufox, M. D., Aurell, M., Bubeck, B., Fommei, E., Piepsz, A., Russell, C. et al: Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med, 37: 1883, 1996
2. Prigent, A., Cosgriff, P., Gates, G. F., Granerus, G., Fine, E. J., Itoh, K. et al: Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: International Consensus Committee from the Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med, 29: 146, 1999
3. Taylor, A., Eshima, D., Fritzberg, A. R., Christian, P. E. and Kasina, S.: Comparison of iodine-131 OIH and technetium-99m-MAG3 renal imaging in volunteers. J Nucl Med, 27: 795, 1986
4. Bubeck, B., Brandau, W., Weber, E., Kalble, T., Parekh, N. and Georgi, P.: Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med, 31: 1285, 1990
5. Itoh, K., Tsukamoto, E., Kakizaki, H., Nonomura, K. and Furudate, M.: Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 1231-orthoiodonippurate. Nucl Med Commun, 14: 644, 1993
6. Najarian, J. S., Chavers, B. M., McHugh, L. E. and Matas, A. J.: 20 Years or more of follow-up of living kidney donors. Lancet, 340: 807, 1992
7. Ben-Haim, S., Sopov, V., Stein, A., Moskovitz, B., Front, A., Mecz, Y. et al: Kidney function after radical nephrectomy: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys. J Nucl Med, 41: 1025, 2000
8. Fritzberg, A. R., Kasina, S., Eshima, D. and Johnson, D. L.: Synthesis and biological evaluation of technetium-99m-MAG3 as a hippuran replacement. J Nucl Med, 27: 111, 1986
9. Itoh, K., Nonomura, K., Yamashita, T., Kanegae, K., Murakumo, M., Koyanagi, T. et al: Quantification of renal function with a count-based gamma camera method using technetium-99m-MAG3 in children. J Nucl Med, 37: 71, 1996
10. Johansson, M. and Moonen, M.: Prediction of post-operative glomerular filtration rate after nephrectomy for renal malignancy. Clin Physiol, 21: 688, 2001
11. Anderson, R. G., Bueschen, A. J., Lloyd, L. K., Dubovsky, E. V. and Burns, J. R.: Short-term and long-term changes in renal function after donor nephrectomy. J Urol, 145: 11, 1991
12. 99Mtechnetium dimercapto-succinic acid renal scintigraphy for predicting postoperative renal insufficiency in patients undergoing nephrectomy. J Urol, 169: 24, 2003